Endocrine DisruptorsPERTHNCT06571994
The Plastic Exposure Reduction Transforms Health Trial
A study testing Low Plastic Intervention in people with Endocrine Disruptors and Inflammation, run by The University of Western Australia at 1 site in Australia.
Trial summary
The goal of this randomized controlled trial is to learn if an intervention of reducing plastic exposure through diet, personal care and cleaning products can improve health outcomes in adult participants with cardiometabolic risk factors. Read more about this study
- Who is it for?
- Ages 18 to 60 yearsHealthy volunteers can take part
- Conditions the study is for
- Endocrine Disruptors, Inflammation, Cardiometabolic Risk Factors
- What is being tested?
- Low Plastic Intervention
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteAustralia
- Study dates
- 5 Sep 2024to 4 Jul 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Biological males or, non-pregnant, non-lactating biological females aged 18 to 60 years.
- For female participants at least one of the following must apply: i) Not of childbearing potential - surgical sterile or postmenopausal (no menses last 12 months and follicle-stimulating hormone (FSH) greater than 40 mIU/mL); ii) Childbearing potential and agrees to practice true abstinence, is in a same-sex relationship or agrees to use effective contraception during the study (either hormonal contraception, intrauterine devices or condom) or has a vasectomised male partner.
- Body mass index ≥30 kg/m2. If outside this range, eligible at investigator's discretion.
- Waist circumference ≥102cm in men and ≥88cm in women. If outside this range, eligible at investigator's discretion.
- Certain medications may be excluded based on investigators discretion.
- Lives in the Perth Metropolitan Area.
Show all 9Show fewer
- Willing to change all they eat, not eat out and not wear makeup for 4 weeks if selected for intervention.
- Ability to give written informed consent.
- Proof of immunisation against COVID-19 (SARS-CoV-2), according to WA Health guidelines at time of recruitment.
Who cannot join
- Any abnormalities in electrocardiogram (ECG) readings, or as per the Investigator's discretion.
- History of drug or alcohol abuse in the past 24 months. Alcohol abuse defined as greater than 21 units/week for males, greater than 14 units/week for females.
- Current regular smoker or e-cigarette use. Social smokers (less than 3 nicotine/tobacco products in the last 3 months) can be included if abstaining for the duration of the study.
- Currently pregnant or planning pregnancy during the course of the study as assessed by pregnancy testing carried out during screening.
- Currently on, or within 3 months of discontinuing, glucagon-like peptide-1 agonists or related compounds. If inside this range, eligible at Investigator's discretion.
- Living in a home that has been renovated in the past 4-weeks.
Show all 11Show fewer
- Have known severe food allergies or anaphylaxis to common food allergens. As per the Investigator's discretion.
- Not suitable for the study for any other reason, as determined by the investigator.
- Acute infection, surgery, vaccination, or other inflammatory process in the previous 2 weeks. Minor procedures are exempt at investigator's discretion.
- Evidence of moderate or greater renal impairment at screening, as indicated by an estimated creatinine clearance of less than 60 mL/min using the Cockcroft-Gault equation.
- Clinically significant abnormal laboratory tests or examination findings, as determined by the investigator, not otherwise mentioned.
Trial locations and contacts
1 site in 1 country.
Australia1 site
Harry Perkins Institute of Medical Research
Nedlands, Western Australia, 6009
About this study
Official title: Examining the Effect of Minimal Plastics Exposure on Plastic-Associated Chemicals (PAC) Excretion and Biomarkers in Adults With Cardiometabolic Risk Factors
The goal of this randomized controlled trial is to learn if an intervention of reducing plastic exposure through diet, personal care and cleaning products can improve health outcomes in adult participants with cardiometabolic risk factors. The main questions it aims to answer are:
- Will the low plastic exposure intervention reduce urinary excretion of bisphenols?
- Will the low plastic exposure intervention reduce urinary excretion of phthalate metabolites?
- Can reducing plastic exposure improve cardiometabolic biomarkers?
Read more
Researchers will compare this 4-week low plastic intervention with a control/no intervention group.
Participants in the intervention group will:
- be provided with food that have no/low plastic and plastic-associated chemicals
- be provided with personal care and cleaning produces that have no/low plastic and plastic-associated chemicals
- replace cooking and food preparation equipment with no/low plastic alternatives
Participants in the control group will not receive the intervention and are not expected to change their behaviour.
All participants will provide biological samples (urine, stool, nasal lavage and blood) at several timepoints during the study and attend 4 clinic visits: screening and before, during and after the intervention. Participants will also complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.
Read the detailed description
Many plastic products contain endocrine disrupting chemicals, such as bisphenols and phthalates (referred to as plastic-associated chemicals or PAC), which leach out from everyday use and enter the human body. Food contaminated from packaging or with plastic particles, personal care and cleaning products may be sources of PAC which can be inhaled or absorbed through the skin. The fundamental premise underpinning the research is that exposure to PAC, combined with genetic and lifestyle factors, creates chronic and systemic inflammation that underpins cardiometabolic conditions.
This randomized controlled trial aims to demonstrate whether decreasing exposure to plastic and PAC will reduce urinary excretion of PAC and improve cardiometabolic biomarkers in people with cardiometabolic risk factors.
Participants that have consented and passed health screening (N=60) will be randomized to one of two parallel groups, to receive a 4-week low plastic intervention in their homes with the support of registered dietitians.
- Group 1 (N=30): low plastic intervention group
- Group 2 (N=30): control/no intervention group
All participants will attend four in-person clinic appointments, one during screening, and three during the intervention (Visit 1: day 0, baseline; Visit 2: day 16, midpoint; and Visit 3: day 29, post intervention), of up to two hours duration each. In addition, participants will have a video/phone appointment between screening and Visit 1.
The day before and after the video/phone appointment, participants will be asked to collect urine, stool and nasal washing samples and send them back the day after their video/phone appointment. At the end of the video/phone appointment, eligible and willing participants will be invited to continue to the intervention study and randomized into either the intervention or control group. At the video/phone appointment, participants from Group 1 will order their food and personal care products. The researchers will send the order to a local meal service delivery who will order, pay for, package, and deliver the approved food to the participants' homes in insulated boxes. Delivery of approved products to participants' homes will take place the day before the intervention begins, and at other pre-determined timepoints throughout the study, as required. Samples of food products will be frozen for retrospective testing for PAC, if exposure testing indicates contamination from an unexpected source. Participants from Group 1 will use only non-plastic cooking utensils provided by the researchers and follow guidance concerning the preparation of their food. Participants from Group 1 will use only personal care and cleaning products supplied by the research team. Personal care products include, but are not limited to shampoo, conditioners, face moisturizers, cleansers, serums, make-up and sunscreens, deodorant, tampons and applicators. Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention.
All participants will be asked to collect urine, stool, and nasal washing samples on days -1, 8, 15, 22 and 28 of the intervention period, and return them at the clinic visits. During the clinic visits, participants will have fasting blood sample taken, complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall - plastic exposure (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.
For intervention adherence the following assessment tools will be employed:
24-hour dietary recall - plastic exposure interview (24DR-PE): This assessment is a researcher-administered, computer-assisted, 24-hour dietary recall interview. The method assesses dietary intake on the preceding 24-hour period. The method is adapted to gather additional information concerning the packaging, storage, and preparation of food by the participants. Trained dietitians will carry out the interviews during the clinic visits. The interviews will vary in length between 15 and 60 minutes depending on the stage of the study, and the complexity of each participants' diet. They will be carried out once during screening and three times during the 4-week intervention.
24-hour personal care product recall (24HR-PPR): This is a self-administered questionnaire for the 24-hour recall of personal care products use. This assessment will be conducted once during screening and three times during the 4-week intervention. The questionnaire consists of 15 questions and will take between 2 and 5 minutes to complete.
Post-trial survey: This survey will be conducted to identify any difficulties experienced by the participants that might have affected their adherence to the intervention and procedures.
Tolerability and feasibility qualitative interview: To evaluate the tolerability and feasibility of the trial intervention, participants will be invited to participate in a phone interview within two weeks of completing the intervention. A trained interviewer will conduct the interviews using a structured guide that includes both closed and open-ended questions. Each interview is expected to last 20-40 minutes.
- Being tested
- Low Plastic Intervention
- Keywords
- Plastic, Microplastic, Nanoplastic, Plastic associated chemicals, Bisphenols, Phthalates, Inflammation
- Medical subject headings
- Inflammation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Low Plastic InterventionBehavioural
Participants will be provided with food that contain no or low plastic and PAC. This is defined as minimally processed (according to NOVA Classification) fresh produce where the supply chain is either known to be free, or likely to be free of plastic contamination. Foods that are canned, pickled, use plastic storage containers will be either avoided or substituted where possible with glass. Participants will also follow guidance concerning the preparation of their food. Plastic utensils used in the preparation of food will be substituted for non-plastic. Commonly used personal care products, e.g., shampoo and soaps, and cleaning products will be replaced with no/low PAC alternatives. Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention.
| Study group | Role | What they receive |
|---|---|---|
| Low Plastic Intervention Group | Experimental | 30 participants randomly assigned to the intervention group will consume low PAC food, employ low risk PAC food preparation practices, and use low PAC personal care and cleaning products. Receives: Behavioral: Low Plastic Intervention |
| Control Group | No intervention | 30 participants randomly assigned to the control group will not receive the intervention nor expected to change behaviour. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in bisphenols (composite of bisphenol A, BPA; and bisphenol S, BPS)
Assessed by measuring urinary concentrations (ng/mL) of BPA and BPS and comparing mean percent change
Measured: Baseline and 4 weeks for both groups
Secondary outcomes (7)
Change in bisphenol A (BPA)
Assessed by measuring urinary concentrations BPA (ng/mL) and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in bisphenol S (BPS)
Assessed by measuring urinary concentrations of BPS (ng/mL) and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in diethyl phthalate (DEP)
Assessed by measuring urinary concentrations (ng/mL) of DEP metabolite, mono-ethyl phthalate (MEP), and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in di-n-butyl-phthalate (DnBP)
Assessed by measuring urinary concentrations (ng/mL) of DnBP metabolites, mono-n-butyl-phthalate (MnBP) and mono-(3-carboxypropyl) phthalate (MCPP), and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in di-iso-butyl phthalate (DiBP)
Assessed by measuring urinary concentrations (ng/mL) of DiBP metabolite, mono-iso-butyl phthalate (MiBP), and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in benzyl butyl phthalate (BBP)
Assessed by measuring urinary concentrations (ng/mL) of BBP metabolite, mono-benzyl phthalate (MBzP), and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in di-(2-ethylhexyl) phthalate (DEHP)
Assessed by measuring urinary concentrations (ng/mL) of the composite of DEHP metabolites (mono-2-ethylhexyl phthalate, MEHP; mono-(2-ethyl-5-oxohexyl) phthalate, MEOHP; mono-(2-ethyl-5-hydroxyhexyl) phthalate, MEHHP; and mono-(2-ethyl-5-carboxypentyl) phthalate, MECPP) and compare mean percent change
Measured: Baseline, and 1, 2, 3 and 4 weeks for both groups
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Aug 2024
- Study start5 Sep 2024
- Primary completion3 Jul 2025
- Study completion4 Jul 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Endocrine DisruptorsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 60 participants (actual)
Sponsor and investigators
- Lead sponsor
- The University of Western Australia
- Sponsor type
- University, hospital or other
- Collaborators
- Minderoo Foundation
- Responsible party
- Principal investigator, Michaela Lucas, The University of Western Australia
- Investigators
- Michaela Lucas, Principal investigator, The University of Western Australia
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06571994
- Sponsor's protocol ID
- 2021_ET001118
- Acronym
- PERTH
- Status last verified
- Dec 2025
- First submitted
- 31 Jul 2024
- Last updated
- 22 Dec 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: At this stage of the study the investigators do not plan to share IPD but this decision may be reviewed in the future.
Publications
Lucas A, Harray A, Duong L, Herrmann S, Vlaskovsky P, Trevenen M, Chan D, Papendorf H, Smith T, Flint L, Liu A, Gaudieri S, Wang X, Mueller JF, Thomas KV, Murray K, Symeonides C, Dunlop S, Watts G, Lucas M. Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial - a protocol. BMJ Open. 2025 Aug 25;15(8):e099330. doi: 10.1136/bmjopen-2025-099330.
PubMed 40854835
Study at a glance
From the registry record, last updated by the sponsor on 22 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Examining the Effect of Minimal Plastics Exposure on Plastic-Associated Chemicals (PAC) Excretion and Biomarkers in Adults With Cardiometabolic Risk Factors
- ClinicalTrials.gov ID
- NCT06571994
- Acronym / sponsor ID
- PERTH / 2021_ET001118
- Keywords
- Plastic, Microplastic, Nanoplastic, Plastic associated chemicals, Bisphenols, Phthalates, Inflammation
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 60 participants (actual)
- Lead sponsor
- The University of Western AustraliaUniversity, hospital or other
- Collaborators
- Minderoo Foundation
- Study start
- 5 Sep 2024 (actual)
- Primary completion
- 3 Jul 2025 (actual)
- Study completion
- 4 Jul 2025 (actual)
- First posted
- 26 Aug 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this randomized controlled trial is to learn if an intervention of reducing plastic exposure through diet, personal care and cleaning products can improve health outcomes in adult participants with cardiometabolic risk factors. The main questions it aims to answer are:
- Will the low plastic exposure intervention reduce urinary excretion of bisphenols?
- Will the low plastic exposure intervention reduce urinary excretion of phthalate metabolites?
- Can reducing plastic exposure improve cardiometabolic biomarkers?
Researchers will compare this 4-week low plastic intervention with a control/no intervention group.
Participants in the intervention group will:
- be provided with food that have no/low plastic and plastic-associated chemicals
- be provided with personal care and cleaning produces that have no/low plastic and plastic-associated chemicals
- replace cooking and food preparation equipment with no/low plastic alternatives
Participants in the control group will not receive the intervention and are not expected to change their behaviour.
All participants will provide biological samples (urine, stool, nasal lavage and blood) at several timepoints during the study and attend 4 clinic visits: screening and before, during and after the intervention. Participants will also complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.
Detailed description
Many plastic products contain endocrine disrupting chemicals, such as bisphenols and phthalates (referred to as plastic-associated chemicals or PAC), which leach out from everyday use and enter the human body. Food contaminated from packaging or with plastic particles, personal care and cleaning products may be sources of PAC which can be inhaled or absorbed through the skin. The fundamental premise underpinning the research is that exposure to PAC, combined with genetic and lifestyle factors, creates chronic and systemic inflammation that underpins cardiometabolic conditions.
This randomized controlled trial aims to demonstrate whether decreasing exposure to plastic and PAC will reduce urinary excretion of PAC and improve cardiometabolic biomarkers in people with cardiometabolic risk factors.
Participants that have consented and passed health screening (N=60) will be randomized to one of two parallel groups, to receive a 4-week low plastic intervention in their homes with the support of registered dietitians.
- Group 1 (N=30): low plastic intervention group
- Group 2 (N=30): control/no intervention group
All participants will attend four in-person clinic appointments, one during screening, and three during the intervention (Visit 1: day 0, baseline; Visit 2: day 16, midpoint; and Visit 3: day 29, post intervention), of up to two hours duration each. In addition, participants will have a video/phone appointment between screening and Visit 1.
The day before and after the video/phone appointment, participants will be asked to collect urine, stool and nasal washing samples and send them back the day after their video/phone appointment. At the end of the video/phone appointment, eligible and willing participants will be invited to continue to the intervention study and randomized into either the intervention or control group. At the video/phone appointment, participants from Group 1 will order their food and personal care products. The researchers will send the order to a local meal service delivery who will order, pay for, package, and deliver the approved food to the participants' homes in insulated boxes. Delivery of approved products to participants' homes will take place the day before the intervention begins, and at other pre-determined timepoints throughout the study, as required. Samples of food products will be frozen for retrospective testing for PAC, if exposure testing indicates contamination from an unexpected source. Participants from Group 1 will use only non-plastic cooking utensils provided by the researchers and follow guidance concerning the preparation of their food. Participants from Group 1 will use only personal care and cleaning products supplied by the research team. Personal care products include, but are not limited to shampoo, conditioners, face moisturizers, cleansers, serums, make-up and sunscreens, deodorant, tampons and applicators. Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention.
All participants will be asked to collect urine, stool, and nasal washing samples on days -1, 8, 15, 22 and 28 of the intervention period, and return them at the clinic visits. During the clinic visits, participants will have fasting blood sample taken, complete the sociodemographic questionnaire, a physical activity assessment using the International Physical Activity Questionnaire (IPAQ - Short Form), the 24-hr personal care product recall questionnaire, the plastic-associated chemicals questionnaire and be interviewed by a member of the research team to complete a 24-hour diet recall - plastic exposure (24DR-PE) of food consumed, and how it was stored prepared, and consumed. The 24DR-PE will facilitate assessments of deviations from the protocol, and enable the assessment of energy, macro and micronutrient intake.
For intervention adherence the following assessment tools will be employed:
24-hour dietary recall - plastic exposure interview (24DR-PE): This assessment is a researcher-administered, computer-assisted, 24-hour dietary recall interview. The method assesses dietary intake on the preceding 24-hour period. The method is adapted to gather additional information concerning the packaging, storage, and preparation of food by the participants. Trained dietitians will carry out the interviews during the clinic visits. The interviews will vary in length between 15 and 60 minutes depending on the stage of the study, and the complexity of each participants' diet. They will be carried out once during screening and three times during the 4-week intervention.
24-hour personal care product recall (24HR-PPR): This is a self-administered questionnaire for the 24-hour recall of personal care products use. This assessment will be conducted once during screening and three times during the 4-week intervention. The questionnaire consists of 15 questions and will take between 2 and 5 minutes to complete.
Post-trial survey: This survey will be conducted to identify any difficulties experienced by the participants that might have affected their adherence to the intervention and procedures.
Tolerability and feasibility qualitative interview: To evaluate the tolerability and feasibility of the trial intervention, participants will be invited to participate in a phone interview within two weeks of completing the intervention. A trained interviewer will conduct the interviews using a structured guide that includes both closed and open-ended questions. Each interview is expected to last 20-40 minutes.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Low Plastic Intervention Group | Experimental | Behavioral: Low Plastic Intervention30 participants randomly assigned to the intervention group will consume low PAC food, employ low risk PAC food preparation practices, and use low PAC personal care and cleaning products. |
| Control Group | No intervention | –30 participants randomly assigned to the control group will not receive the intervention nor expected to change behaviour. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (9 listed)
- Biological males or, non-pregnant, non-lactating biological females aged 18 to 60 years.
- Body mass index ≥30 kg/m2. If outside this range, eligible at investigator's discretion.
- Waist circumference ≥102cm in men and ≥88cm in women. If outside this range, eligible at investigator's discretion.
- Certain medications may be excluded based on investigators discretion.
- Lives in the Perth Metropolitan Area.
Key exclusion criteria (11 listed)
- Any abnormalities in electrocardiogram (ECG) readings, or as per the Investigator's discretion.
- History of drug or alcohol abuse in the past 24 months. Alcohol abuse defined as greater than 21 units/week for males, greater than 14 units/week for females.
- Current regular smoker or e-cigarette use. Social smokers (less than 3 nicotine/tobacco products in the last 3 months) can be included if abstaining for the duration of the study.
- Currently pregnant or planning pregnancy during the course of the study as assessed by pregnancy testing carried out during screening.
- Currently on, or within 3 months of discontinuing, glucagon-like peptide-1 agonists or related compounds. If inside this range, eligible at Investigator's discretion.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Low Plastic InterventionParticipants will be provided with food that contain no or low plastic and PAC. This is defined as minimally processed (according to NOVA Classification) fresh produce where the supply chain is either known to be free, or likely to be free of plastic contamination. Foods that are canned, pickled, use plastic storage containers will be either avoided or substituted where possible with glass. Participants will also follow guidance concerning the preparation of their food. Plastic utensils used in the preparation of food will be substituted for non-plastic. Commonly used personal care products, e.g., shampoo and soaps, and cleaning products will be replaced with no/low PAC alternatives. Participants will be supplied with a comprehensive schedule, and instructions for the 4-week intervention. | Behavioural | Low Plastic Intervention Group |
Primary outcome
Change in bisphenols (composite of bisphenol A, BPA; and bisphenol S, BPS)
Time frame: Baseline and 4 weeks for both groups
Assessed by measuring urinary concentrations (ng/mL) of BPA and BPS and comparing mean percent change
7 secondary outcomes
Change in bisphenol A (BPA)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in bisphenol S (BPS)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in diethyl phthalate (DEP)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in di-n-butyl-phthalate (DnBP)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in di-iso-butyl phthalate (DiBP)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in benzyl butyl phthalate (BBP)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Change in di-(2-ethylhexyl) phthalate (DEHP)
Time frame: Baseline, and 1, 2, 3 and 4 weeks for both groups
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Dec 2025.
- Derived from this study: PubMed 40854835Lucas A, Harray A, Duong L, Herrmann S, Vlaskovsky P, Trevenen M, Chan D, Papendorf H, Smith T, Flint L, Liu A, Gaudieri S, Wang X, Mueller JF, Thomas KV, Murray K, Symeonides C, Dunlop S, Watts G, Lucas M. Randomised controlled trial of a low plastic diet and lifestyle intervention for adults with cardiometabolic risk factors: the Plastic Exposure Reduction Transforms Health (PERTH) trial - a protocol. BMJ Open. 2025 Aug 25;15(8):e099330. doi: 10.1136/bmjopen-2025-099330.
- Individual participant dataSharing planned: No. At this stage of the study the investigators do not plan to share IPD but this decision may be reviewed in the future.
Related trials for Endocrine Disruptors
Not yet recruiting
Sperm, Exposure and Endocrine Disruptors
Fertility, Male Fertility
Active, not recruiting
Weight Loss and Endocrine Disrupting Chemicals (EDCs): Lifestyle Interventions to Lose Weight and Reduce EDC Exposure in Individuals With Overweight/Obesity
Obesity &Amp;Amp;Amp; Overweight, Environmental Exposure
Active, not recruitingObservational study
Everyday Exposures: How Chemicals and Weight Impact Breast Cancer Risk
Breast Cancer
Not yet recruiting
Plastic Detox During IVF Treatment
Infertility (IVF Patients)
Not yet recruiting
Reducing Endocrine-Disrupting Chemical Exposure in Reproductive-Age Women: A Pender Model-Based RCT
Women Who Are Aged 18-49 Years, Able to Read, Write
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Michaela Lucas principal investigator
The University of Western Australia
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Low Plastic Intervention in people with Endocrine Disruptors and Inflammation, run by The University of Western Australia at 1 site in Australia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Australia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in bisphenols (composite of bisphenol A, BPA; and bisphenol S, BPS) (time frame: Baseline and 4 weeks for both groups). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06571994, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2025.